|
PRIM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.983800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.084100E-02 |
| Normal-vs-Stage2 |
2.971200E-01 |
| Normal-vs-Stage3 |
2.976200E-01 |
| Normal-vs-Stage4 |
8.895400E-03 |
| Stage1-vs-Stage2 |
4.828000E-01 |
| Stage1-vs-Stage3 |
1.711830E-01 |
| Stage1-vs-Stage4 |
1.318010E-01 |
| Stage2-vs-Stage3 |
7.885200E-01 |
| Stage2-vs-Stage4 |
9.533600E-02 |
| Stage3-vs-Stage4 |
3.351600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.902070E-02 |
| Normal-vs-AfricanAmerican |
8.633200E-01 |
| Normal-vs-Asian |
2.060200E-01 |
| Caucasian-vs-AfricanAmerican |
5.793600E-02 |
| Caucasian-vs-Asian |
6.209800E-01 |
| AfricanAmerican-vs-Asian |
2.409400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.643600E-02 |
| Normal-vs-Female |
8.563900E-02 |
| Male-vs-Female |
3.507200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.752190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.928350E-02 |
| Normal-vs-Age(61-80Yrs) |
6.118100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.757600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.785800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.473800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.146010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.959250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197820E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.020580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.478300E-02 |
| Normal-vs-Grade 2 |
3.392400E-02 |
| Normal-vs-Grade 3 |
6.066100E-02 |
| Normal-vs-Grade 4 |
6.448400E-02 |
| Grade 1-vs-Grade 2 |
3.286400E-01 |
| Grade 1-vs-Grade 3 |
2.415400E-01 |
| Grade 1-vs-Grade 4 |
9.799800E-01 |
| Grade 2-vs-Grade 3 |
7.278800E-01 |
| Grade 2-vs-Grade 4 |
4.587200E-01 |
| Grade 3-vs-Grade 4 |
3.735600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.931500E-02 |
| Normal-vs-ccB subtype |
1.010440E-01 |
| ccA subtype-vs-ccB subtype |
4.117400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.555710E-02 |
| Normal-vs-N1 |
4.579700E-02 |
| N0-vs-N1 |
3.747800E-01 |
|
|
